These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9840414)
1. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. Lynch NJ; Nimmo MA Eur J Appl Physiol Occup Physiol; 1998 Nov; 78(6):565-72. PubMed ID: 9840414 [TBL] [Abstract][Full Text] [Related]
2. Measuring performance during the menstrual cycle: a model using oral contraceptives. Redman LM; Weatherby RP Med Sci Sports Exerc; 2004 Jan; 36(1):130-6. PubMed ID: 14707778 [TBL] [Abstract][Full Text] [Related]
3. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781 [TBL] [Abstract][Full Text] [Related]
4. Low dosage monophasic oral contraceptive use and intermittent exercise performance and metabolism in humans. Lynch NJ; De Vito G; Nimmo MA Eur J Appl Physiol; 2001 Apr; 84(4):296-301. PubMed ID: 11374113 [TBL] [Abstract][Full Text] [Related]
5. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea. Vescovi JD; VanHeest JL; De Souza MJ Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672 [TBL] [Abstract][Full Text] [Related]
6. Effect of the menstrual cycle on performance of intermittent, high-intensity shuttle running in a hot environment. Sunderland C; Nevill M Eur J Appl Physiol; 2003 Jan; 88(4-5):345-52. PubMed ID: 12527962 [TBL] [Abstract][Full Text] [Related]
7. Effects of oral contraceptives on peak exercise capacity. Casazza GA; Suh SH; Miller BF; Navazio FM; Brooks GA J Appl Physiol (1985); 2002 Nov; 93(5):1698-702. PubMed ID: 12381756 [TBL] [Abstract][Full Text] [Related]
9. Changes in insulin receptors during oral contraception. De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643 [TBL] [Abstract][Full Text] [Related]
10. Menstrual cycle and oral contraceptives' effects on growth hormone response to sprinting. Sunderland C; Tunaley V; Horner F; Harmer D; Stokes KA Appl Physiol Nutr Metab; 2011 Aug; 36(4):495-502. PubMed ID: 21848445 [TBL] [Abstract][Full Text] [Related]
11. Rationale for new oral contraceptive dosing. Williams JK Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507 [TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
13. Estrogen modifies the temperature effects of progesterone. Stachenfeld NS; Silva C; Keefe DL J Appl Physiol (1985); 2000 May; 88(5):1643-9. PubMed ID: 10797125 [TBL] [Abstract][Full Text] [Related]
14. [Hemodynamics and ergometric performance modified by low dosage oral contraceptives]. Hartard M; Haber P; Havelec L; Jeschke D Zentralbl Gynakol; 1996; 118(1):37-41. PubMed ID: 8588450 [TBL] [Abstract][Full Text] [Related]